Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Thornton

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Neurologic Clinics|August 1, 2006
Psychoneuroimmunology of strokeRobert Skinner, Rachel Georgiou, Peter Thornton, et al.
Journal of Neurochemistry|March 15, 2021
CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesionClaire Ann Butler, Peter Thornton, Guy Charles Brown
Immunology and Allergy Clinics of North America|April 25, 2009
Psychoneuroimmunology of strokeRobert Skinner, Rachel Georgiou, Peter Thornton, et al.
Molecular and Cellular Neurosciences|October 18, 2007
Matrix metalloproteinase-9 and urokinase plasminogen activator mediate interleukin-1-induced neurotoxicityPeter Thornton, Emmanuel Pinteaux, Stuart M Allan, et al.
Current Neurovascular Research|September 22, 2010
Interleukin-1 drives cerebrovascular inflammation via MAP kinase-independent pathwaysPeter Thornton, Barry W McColl, Laura Cooper, et al.
Journal of Neurochemistry|June 30, 2006
Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical releasePeter Thornton, Emmanuel Pinteaux, Rosemary M Gibson, et al.
Pain|December 24, 2016
Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivityCarl I Webster, Jon Hatcher, Matthew Burrell, et al.
Blood|March 5, 2010
Platelet interleukin-1alpha drives cerebrovascular inflammationPeter Thornton, Barry W McColl, Andrew Greenhalgh, et al.
Obesity (Silver Spring, Md.)|April 30, 2025
The NLRP3 inhibitor NT-0796 enhances and sustains GLP-1R agonist-mediated weight loss in a murine diet-induced obesity modelPeter Thornton, Valérie Reader, Zsofia Digby, et al.
Nucleic Acids Research|December 12, 2023
cGAS-STING signalling regulates microglial chemotaxis in genome instabilityEmily J Talbot, Lisha Joshi, Peter Thornton, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Neurologic Clinics|August 1, 2006
Psychoneuroimmunology of strokeRobert Skinner, Rachel Georgiou, Peter Thornton, et al.
Journal of Neurochemistry|March 15, 2021
CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesionClaire Ann Butler, Peter Thornton, Guy Charles Brown
Immunology and Allergy Clinics of North America|April 25, 2009
Psychoneuroimmunology of strokeRobert Skinner, Rachel Georgiou, Peter Thornton, et al.
Molecular and Cellular Neurosciences|October 18, 2007
Matrix metalloproteinase-9 and urokinase plasminogen activator mediate interleukin-1-induced neurotoxicityPeter Thornton, Emmanuel Pinteaux, Stuart M Allan, et al.
Current Neurovascular Research|September 22, 2010
Interleukin-1 drives cerebrovascular inflammation via MAP kinase-independent pathwaysPeter Thornton, Barry W McColl, Laura Cooper, et al.
Journal of Neurochemistry|June 30, 2006
Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical releasePeter Thornton, Emmanuel Pinteaux, Rosemary M Gibson, et al.
Pain|December 24, 2016
Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivityCarl I Webster, Jon Hatcher, Matthew Burrell, et al.
Blood|March 5, 2010
Platelet interleukin-1alpha drives cerebrovascular inflammationPeter Thornton, Barry W McColl, Andrew Greenhalgh, et al.
Obesity (Silver Spring, Md.)|April 30, 2025
The NLRP3 inhibitor NT-0796 enhances and sustains GLP-1R agonist-mediated weight loss in a murine diet-induced obesity modelPeter Thornton, Valérie Reader, Zsofia Digby, et al.
Nucleic Acids Research|December 12, 2023
cGAS-STING signalling regulates microglial chemotaxis in genome instabilityEmily J Talbot, Lisha Joshi, Peter Thornton, et al.
Pageof 3